N. Maillard
Centre Hospitalier Universitaire de Saint-Étienne(FR)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study(2002)143 cited
- → Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient(2007)112 cited
- → HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM(2015)84 cited
- → Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects(2007)63 cited
- → Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire(2011)51 cited
- → Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT(2016)46 cited
- → Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy(2017)36 cited
- → Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC(2016)32 cited
- → Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study(2009)29 cited
- → The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients(2006)21 cited